carcinoma in situ
[肿瘤] 原位癌
2026-03-20 20:13 浏览次数 20
[肿瘤] 原位癌
objective to evaluate the ro le of periductal microvessel density (mvd) in predicting the transformation from ductal carcinoma in situ (dcis) to invasive carcinoma in breast.
目的评价围管性微血管密度(mvd)在预测乳腺导管内癌向浸润性癌转化中的价值。
ultrathin sections of 11 cases of carcinoma in situ and early invasive cancer of uterine cervix were observed with tem and controlled with 5 cases of advanced cancer.
本文采用超薄切片法,对11例宫颈原位癌及早期浸润癌进行了透射电镜观察,并对5例晚期宫颈癌进行了对照分析。
these lesions included ductal carcinoma in situ (dcis), invasive lobular cancer, cysts, and fibroadenomas.
病变包括乳腺导管原位癌,侵袭性小叶癌,囊肿。
09052808】 women with ductal carcinoma in situ (dcis) who exhibit an overexpression of the protein her2/neu have a six-fold increase in risk of invasive breast cancer, according to a new study.
患有乳腺导管内原位癌(ductal carcinoma in situdcis)的女性,如果其her2/neu原癌基因编码表达产生的蛋白质水平过高,那么其患侵入性乳腺癌的可能性将提高6倍。
lobular carcinoma in situ is not known to progress to microinvasive disease.
小叶原位癌不知道进展微创疾病。
conclusion cyctomastopathy atypical hyperplasia was regarded as an important pathologic change was breast cancer, and it can develop carcinoma in situ under given conditions.
结论乳腺增生癥中不典型增生为重要癌旁病变,在一定条件下可发展成原位癌。
conclusions there are three patterns in both cytology and histology of thyroid atypical adenoma, belonging to carcinoma in situ in biologic behaviour.
结论甲状腺非典型腺瘤组织学和细胞学均分为三型,生物学行为系原位癌。
although this feature is rare, the current under standing that lobular carcinoma in situ is a marker needs to be revised.
虽然这一功能是非常罕见,目前根据长期的小叶原位癌是一个标记需要修改。
the large cells infiltrating into the epidermis represent intraepithelial extension of an underlying ductal carcinoma in situ or invasive ductal carcinoma.
浸润至真皮的大细胞说明位于下方的导管原位癌或浸润 性导管癌向上皮内侵犯。
in ducts with atypical hyperplasia in proliferative breast disease and lobular carcinoma in situ there was attenuation because of the suppression of the hyperplasia of the ductal wall.
乳腺增生病腺上皮细胞不典型增生和小叶原位癌因细胞过度增生压迫管壁致阳性物萎缩。
intravesical treatment is used for carcinoma in situ and other high grade non-muscle-invasive tumours.
对于原位细胞癌及其他高分级的非肌层浸润性肿瘤可采用膀胱内治疗。
there was also significant difference between ductal carcinoma in situ (or with early infiltration) and invasive ductal carcinoma (p0.05), and the former was weaker.
导管内癌(或伴早浸)与浸润性导管癌相比,表达水平低,差异有显着性意义(p0.05)。
carcinoma in situ is proliferation of cancer cells within ducts or lobules and without invasion of stromal tissue.
原位癌为乳腺管或小叶内的癌细胞增生,无间质组织的浸润。
methods the breast sonograms in 20 cases with ductal carcinoma in situ were analysed and compared with pathology.
方法对20例经病理确诊患者的声像图资料,结合病理进行综合分析。
screening picks up more cases of ductal carcinoma in situ (dcis) - cancer in cells lining the milk ducts that has not spread - than would normally be found because it is often symptomless.
做乳腺癌筛选的好处是能够使女性更早地发现是否已患乳腺导管管内原位癌(dcis,是一种肿瘤性导管内病变其特征是上皮细胞增生显着细胞明显异型 有发展为乳腺浸润癌的倾向),因为管内原位癌的发生通常是没有征兆的。